Latest & greatest articles for breast cancer screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on breast cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for breast cancer screening

61. Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study.

Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study. OBJECTIVE: To assess the incidence of early stage and advanced stage breast cancer before and after the implementation of mass screening in women aged 70-75 years in the Netherlands in 1998. DESIGN: Prospective nationwide population based study. SETTING: National cancer registry, the Netherlands. PARTICIPANTS: Patients aged 70-75 years with a diagnosis of invasive (...) or ductal carcinoma in situ breast cancer between 1995 and 2011 (n=25,414). Incidence rates were calculated using population data from Statistics Netherlands. MAIN OUTCOME MEASURE: Incidence rates of early stage (I, II, or ductal carcinoma in situ) and advanced stage (III and IV) breast cancer before and after implementation of screening. Hypotheses were formulated before data collection. RESULTS: The incidence of early stage tumours significantly increased after the extension for implementation

BMJ2014 Full Text: Link to full Text with Trip Pro

62. Population screening for breast cancer: expectations and developments

Population screening for breast cancer: expectations and developments Population screening for breast cancer: expectations and developments Population screening for breast cancer: expectations and developments Health Council of the Netherlands Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Council of the Netherlands. Population screening for breast (...) cancer: expectations and developments. The Hague: Health Council of the Netherlands Gezondheidsraad (GR). 2014/01E. 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Early Detection of Cancer; Humans; Mammography; Mass Screening; Netherlands Language Published English Country of organisation Netherlands English summary An English language summary is available. Address for correspondence Postbus 16052, 2500 BB Den Haag, The Netherlands. Tel: +31 70 340

Health Technology Assessment (HTA) Database.2014

63. Use of Digital Breast Tomosynthesis with Mammography for Breast Cancer Screening or Diagnosis

Use of Digital Breast Tomosynthesis with Mammography for Breast Cancer Screening or Diagnosis Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) BlueCross BlueShield Association. Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 28(6). 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasmss; Imaging, Three-Dimensional; Mammography; Mass Screening Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence

Health Technology Assessment (HTA) Database.2014

64. Special Report: Screening Asymptomatic Women with Dense Breasts and Normal Mammograms for Breast Cancer

Special Report: Screening Asymptomatic Women with Dense Breasts and Normal Mammograms for Breast Cancer Special report: screening asymptomatic women with dense breasts and normal mammograms for breast cancer Special report: screening asymptomatic women with dense breasts and normal mammograms for breast cancer BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation BlueCross BlueShield Association. Special report: screening asymptomatic women with dense breasts and normal mammograms for breast cancer. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 28(15). 2014 Final publication URL PubMedID Indexing Status Subject indexing assigned by NLM MeSH Asymptomatic Diseases; Blue Cross Blue Shield Insurance Plans; Breast /anatomy & Breast Neoplasms /diagnosis; Combined Modality Therapy; Diagnostic Imaging /methods; Females

Health Technology Assessment (HTA) Database.2014

65. BreathLink? for breast cancer screening

BreathLink? for breast cancer screening BreathLink™ for breast cancer screening BreathLink™ for breast cancer screening NIHR HSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSC. BreathLink™ for breast cancer screening. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon Scanning Review. 2014 Final publication URL (...) Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasmss; Early Detection of Cancer; Mass Screening Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health&Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831

Health Technology Assessment (HTA) Database.2014

66. Breast cancer screening using tomosynthesis in combination with digital mammography.

Breast cancer screening using tomosynthesis in combination with digital mammography. IMPORTANCE: Mammography plays a key role in early breast cancer detection. Single-institution studies have shown that adding tomosynthesis to mammography increases cancer detection and reduces false-positive results. OBJECTIVE: To determine if mammography combined with tomosynthesis is associated with better performance of breast screening programs in the United States. DESIGN, SETTING, AND PARTICIPANTS (...) : Retrospective analysis of screening performance metrics from 13 academic and nonacademic breast centers using mixed models adjusting for site as a random effect. EXPOSURES: Period 1: digital mammography screening examinations 1 year before tomosynthesis implementation (start dates ranged from March 2010 to October 2011 through the date of tomosynthesis implementation); period 2: digital mammography plus tomosynthesis examinations from initiation of tomosynthesis screening (March 2011 to October 2012

JAMA2014

67. Modern mammography screening and breast cancer mortality: population study.

Modern mammography screening and breast cancer mortality: population study. OBJECTIVE: To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. DESIGN: Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent (...) to women aged 50-69 years. PARTICIPANTS: All Norwegian women aged 50-79 between 1986 and 2009. MAIN OUTCOME MEASURES: Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation

BMJ2014 Full Text: Link to full Text with Trip Pro

68. A systematic assessment of benefits and risks to guide breast cancer screening decisions.

A systematic assessment of benefits and risks to guide breast cancer screening decisions. IMPORTANCE: Breast cancer is the second leading cause of cancer deaths among US women. Mammography screening may be associated with reduced breast cancer mortality but can also cause harm. Guidelines recommend individualizing screening decisions, particularly for younger women. OBJECTIVES: We reviewed the evidence on the mortality benefit and chief harms of mammography screening and what is known about how (...) guidelines. RESULTS: Mammography screening is associated with a 19% overall reduction of breast cancer mortality (approximately 15% for women in their 40s and 32% for women in their 60s). For a 40- or 50-year-old woman undergoing 10 years of annual mammograms, the cumulative risk of a false-positive result is about 61%. About 19% of the cancers diagnosed during that 10-year period would not have become clinically apparent without screening (overdiagnosis), although there is uncertainty about

JAMA2014

69. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. 24519768 2014 02 12 2014 03 05 2017 02 20 1756-1833 348 2014 Feb 11 BMJ (Clinical research ed.) BMJ Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. g366 10.1136/bmj.g366 bmj.g366 To compare breast cancer incidence and mortality up to 25 years in women (...) arm and all women aged 50-59 in both arms received annual physical breast examinations. Women aged 40-49 in the control arm received a single examination followed by usual care in the community. Deaths from breast cancer. During the five year screening period, 666 invasive breast cancers were diagnosed in the mammography arm (n=44,925 participants) and 524 in the controls (n=44,910), and of these, 180 women in the mammography arm and 171 women in the control arm died of breast cancer during the 25

BMJ2014 Full Text: Link to full Text with Trip Pro

70. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. OBJECTIVE: To compare breast cancer incidence and mortality up to 25 years in women aged 40-59 who did or did not undergo mammography screening. DESIGN: Follow-up of randomised screening trial by centre coordinators, the study's central office, and linkage to cancer registries and vital statistics databases. SETTING: 15 screening centres in six (...) : Deaths from breast cancer. RESULTS: During the five year screening period, 666 invasive breast cancers were diagnosed in the mammography arm (n=44,925 participants) and 524 in the controls (n=44,910), and of these, 180 women in the mammography arm and 171 women in the control arm died of breast cancer during the 25 year follow-up period. The overall hazard ratio for death from breast cancer diagnosed during the screening period associated with mammography was 1.05 (95% confidence interval 0.85

BMJ2014

71. Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening

Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Computer (...) -aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2014 Authors' objectives Computer-aided detection (CAD) for breast cancer screening involves the use of computer-based algorithms to identify potentially malignant abnormalities in radiographic images, which may help to reduce mortality. The goals of using CAD are to minimize false-positives that lead to unnecessary diagnostic testing and to minimize false

Health Technology Assessment (HTA) Database.2014

72. Digital breast tomosynthesis for breast cancer diagnosis and screening

Digital breast tomosynthesis for breast cancer diagnosis and screening Digital breast tomosynthesis for breast cancer diagnosis and screening Digital breast tomosynthesis for breast cancer diagnosis and screening Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Digital breast tomosynthesis for breast cancer diagnosis and screening. Lansdale: HAYES, Inc (...) .. Directory Publication. 2014 Timeliness warning This report has been archived and may contain outdated information. To request a copy of the report please contact the organisation directly. Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Early Detection of Cancer; Females; Imaging, Three-Dimensional; Mammography; Mass Screening; Radiographic Image Enhancement; Safety; Sensitivity and Specificity; Tomography, X-Ray Computed

Health Technology Assessment (HTA) Database.2014

73. Qualitative?other: Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk

Qualitative?other: Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions

Evidence-Based Nursing (Requires free registration)2014

74. Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines

Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been (...) made for the HTA database. Citation CADTH. Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2014 Authors' conclusions Two systematic reviews, 17 non-randomized studies, and one evidence-based guideline were identified regarding digital tomosynthesis for screening and diagnosis of breast cancer. Final publication URL Indexing Status Subject indexing

Health Technology Assessment (HTA) Database.2014

76. Appropriate imaging for breast cancer screening in special populations

Appropriate imaging for breast cancer screening in special populations Appropriate imaging for breast cancer screening in special populations Appropriate imaging for breast cancer screening in special populations Institute for Clinical and Economic Review (ICER) Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institute for Clinical and Economic Review (ICER (...) ). Appropriate imaging for breast cancer screening in special populations . Boston: Institute for Clinical and Economic Review (ICER). 2014 Authors' conclusions Based on the deliberations of key health outcomes, the committee decided that it had the most complete information: a comprehensive and current evidence report, public comments, and state agency utilization information. The committee concluded that the evidence is sufficient and to cover digital breast tomosynthesis (DBT) for breast cancer screening

Health Technology Assessment (HTA) Database.2014

78. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.

Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Knowledge of the likelihood that a screening-detected case of cancer has been overdiagnosed is vitally important to make treatment decisions and develop screening policy. An overdiagnosed case is an excess case detected by screening. Estimates of the frequency of overdiagnosis in breast and prostate cancer screening vary greatly across studies. This article identifies features (...) of overdiagnosis studies that influence results and shows their effect by using published research. First, different ways to define and measure overdiagnosis are considered. Second, contextual features and how they affect overdiagnosis estimates are examined. Third, the effect of estimation approach is discussed. Many studies use excess incidence under screening as a proxy for overdiagnosis. Others use statistical models to make inferences about lead time or natural history and then derive the corresponding

Annals of Internal Medicine2013 Full Text: Link to full Text with Trip Pro

79. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.

Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. BACKGROUND: Breast cancer is the most common malignant disease diagnosed in women worldwide. Screening with mammography has the ability to detect breast cancer at an early stage. The diagnostic accuracy of mammography screening largely depends on the radiographic density of the imaged breasts. In radiographically dense breasts, non-calcified breast cancers are more (...) likely to be missed than in fatty breasts. As a consequence, some cancers are not detected by mammography screening. Supporters of adjunct ultrasonography to the screening regimen for breast cancer argue that it might be a safe and inexpensive approach to reduce the false negative rates of the screening process. Critics, however, are concerned that performing supplemental ultrasonography on women at average risk will also increase the rate of false positive findings and can lead to unnecessary

Cochrane2013

80. Women's views on overdiagnosis in breast cancer screening: a qualitative study.

Women's views on overdiagnosis in breast cancer screening: a qualitative study. OBJECTIVE: To elicit women's responses to information about the nature and extent of overdiagnosis in mammography screening (detecting disease that would not present clinically during the woman's lifetime) and explore how awareness of overdiagnosis might influence attitudes and intentions about screening. DESIGN: Qualitative study using focus groups that included a presentation explaining overdiagnosis (...) , incorporating different published estimates of its rate (1-10%, 30%, 50%) and information on the mortality benefit of screening, with guided group discussions SETTING: Sydney, Australia PARTICIPANTS: Fifty women aged 40-79 years with no personal history of breast cancer and with varying levels of education and participation in screening. RESULTS: Prior awareness of breast cancer overdiagnosis was minimal. Women generally reacted with surprise, but most came to understand the issue. Responses

BMJ2013 Full Text: Link to full Text with Trip Pro